Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069602 · ClinicalTrials.gov registry record · Phase 4
Assessing Continuous Glucose Monitors in Healthy Children
A Phase 4 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00069602 is a Phase 4 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 20 participants.
The verdict
NCT00069602, a Phase 4 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Continuous glucose monitors may be useful in the treatment of children with Type 1 diabetes mellitus. The purpose of this study was to determine whether two FDA-approved continuous glucose monitors, the Continuous Glucose Monitoring System (CGMS) and the GlucoWatch G2TM Biographer (GW2B), are sufficiently accurate to use in future studies to characterize glucose levels in children.
Interventions
- DEVICE Continuous Glucose Monitoring System (CGMS)
- DEVICE GlucoWatch G2TM Biographer (GW2B)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2002-08 |
| Est. Completion | 2002-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00069602
The ClinicalTrials.gov registry entry for NCT00069602 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitoring System (CGMS) is the first listed.
NCT00069602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00069602 about?
NCT00069602 is a clinical study titled "Assessing Continuous Glucose Monitors in Healthy Children". Continuous glucose monitors may be useful in the treatment of children with Type 1 diabetes mellitus. The purpose of this study was to determine whether two FDA-approved continuous glucose monitors, the Continuous Glucose Monitoring System (CGMS) and the GlucoWatch G2TM Biographer (GW2B), are suffic...
What is the current status of trial NCT00069602?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2002-08. Estimated completion is 2002-11.
What interventions are being tested in trial NCT00069602?
The interventions under investigation include: Continuous Glucose Monitoring System (CGMS) (DEVICE), GlucoWatch G2TM Biographer (GW2B) (DEVICE).
Who is sponsoring clinical trial NCT00069602?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.